Duncan Porter

4.5k citations

65 papers · 2.7k indexed · 1 hit paper · h-index 26

Impact in

Rheumatology top 0.2%
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
- Spondyloarthritis Studies and Treatments
Hematology top 1%
- Autoimmune and Inflammatory Disorders Research

Papers in

Rheumatology 51
- Rheumatoid Arthritis Research and Therapies 48
- Systemic Lupus Erythematosus Research 23
- Spondyloarthritis Studies and Treatments 4
Hematology 19
- Autoimmune and Inflammatory Disorders Research 17

Co-authors: A. Stirling W. Kincaid Alex D. McMahon R. Vallance Hilary A. Capell Peter Lock Iain B. McInnes H A Capell
Journals: Annals of the Rheumatic Diseases (17 papers)RMD Open (5 papers)Lara D. Veeken (4 papers)Arthritis Care & Research (3 papers)Scandinavian Journal of Rheumatology (2 papers)
Partner nations: United Kingdom Canada United States

In The Last Decade

Duncan Porter

64 papers receiving 2.6k citations

Hit Papers

align trajectories log scale

Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial 2004 · 1.0k citations

Peers

Countries citing papers authored by Duncan Porter

Since Specialization

Citations

This map shows the geographic impact of Duncan Porter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Duncan Porter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Duncan Porter more than expected).

Fields of papers citing papers by Duncan Porter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Duncan Porter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Duncan Porter. The network helps show where Duncan Porter may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Duncan Porter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Duncan Porter Line = papers co-authored together Duncan Porter links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Smoking as a risk factor for rheumatoid arthritis: predominant association with IgA autoantibodies – comprehensive analysis of anti-modified protein antibodies with smoking and genetic risk factors in rheumatoid arthritis Arthritis Research & Therapy ·R. A. Framil, Fraser Morton, Junyang Shao, Mafalda Figueira, Annemarie L Dorjée, Duncan Porter, T. Huizinga, Karim Raza, René E. M. Toes, Rachel Knevel, Pascal H P de Jong, Anna Svärd, Diane van der Woude	2025	3
2	OP0122 MACHINE-LEARNING-ASSISTED ANALYSIS IDENTIFIES DISCRETE PHOSPHORYLATION SIGNATURES IN T AND B LYMPHOCYTES ASSOCIATED WITH EARLY RHEUMATOID ARTHRITIS YU Shiy, Moeed Akbar, V. ULLRICH, Carol Wallace, Caron Paterson, Duncan Porter, Delyth M. Reid, Janet Liversidge, Iain B. McInnes, Carl S. Goodyear	2023	2
3	JAK inhibitors disrupt T cell-induced proinflammatory macrophage activation RMD Open ·YU Shiy, Jagtar Singh Nijjar, Laure Foucher, Derek S. Gilchrist, Duncan Porter, Stefan Siebert, Carl S. Goodyear, Iain B. McInnes	2023	11
4	Classification criteria: time for a rethink? Annals of the Rheumatic Diseases ·Duncan Porter, Neil Basu, Stefan Siebert	2020	6
5	Targeting ultrasound remission in early rheumatoid arthritis: the results of the TaSER study, a randomised clinical trial Annals of the Rheumatic Diseases ·James Dale, A. Stirling, Ruiqi Zhang, David Purves, Jonathan H. Foley, Kelly Weiler, Philip G. Conaghan, Désirée van der Heijde, Alex McConnachie, Iain B. McInnes, Duncan Porter	2016	147
6	Tumour necrosis factor inhibition versus rituximab for patients with rheumatoid arthritis who require biological treatment (ORBIT): an open-label, randomised controlled, non-inferiority, trial The Lancet ·Duncan Porter, Hon. David Pryor, James Dale, Claudia‐Martina Messow, Alex McConnachie, Andrew Walker, Robin Munro, John McLaren, Euan McRorie, Jon Packham, Christopher D. Buckley, Boby Ferza Ramadhan, Peter C. Taylor, Ernest Choy, Costantino Pitzalis, Iain B. McInnes	2016	85
7	The Scottish Early Rheumatoid Arthritis (SERA) Study: an inception cohort and biobank BMC Musculoskeletal Disorders ·James Dale, Caron Paterson, Ann Tierney, Stuart H. Ralston, David M. Reid, Neil Basu, Boby Ferza Ramadhan, Neil D McKay, Nadeeshani Jayasinghe, Hilary Wilson, Robin Munro, Ruth Richmond, Derek Baxter, Michael McMahon, John McLaren, Винод Кумар, Stefan Siebert, Iain B. McInnes, Duncan Porter	2016	23
8	Identification of Urinary Peptide Biomarkers Associated with Rheumatoid Arthritis PLoS ONE ·Angélique Stalmach, E. A. Garcia-Zepada, Iain B. McInnes, Holger Husi, Julie Klein, Mohammed Dakna, William Mullen, Harald Mischak, Duncan Porter	2014	28
9	How low to aim in rheumatoid arthritis? Learning from other disciplines Annals of the Rheumatic Diseases ·Duncan Porter, James Dale, Naveed Sattar	2013	7
10	Treat-to-Target in Rheumatoid Arthritis: Clinical and PharmacoEconomic Considerations Clinical and Experimental Rheumatology ·Ariel Béresniak, Jürgen Braun, Paolo Angelo Cortesi, Gianfranco Ferraccioli, Merete Lund Hetland, Johannes W G Jacobs, Arthur Kavanaugh, Raashid Luqmani, Marta Mosca, Theodore Pincus, Duncan Porter, Vappu Rantalaiho, Angelo Ravelli, David L. Scott, Josef S Smolen, Gonzalo Maradones Viviani, Giuseppe Turchetti, Marianne van den Broek, Yusuf Yazıcı	2012	3
11	Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial The Lancet ·王建昌, Hilary A. Capell, A. Stirling, Alex D. McMahon, Peter Lock, R. Vallance, Duncan Porter, W. Kincaid Hit paper breakdown →	2004	1029
12	Lifestyle Influences on Outcome in Rheumatoid Arthritis Scottish Medical Journal ·Jennifer D. Hamilton, 严济良, Duncan Porter, John Hunter, Rajan Madhok, H A Capell	2000	8
13	Early referral, diagnosis, and treatment of rheumatoid arthritis: evidence for changing medical practice Annals of the Rheumatic Diseases ·S. Rodman Irvine, Robin Munro, Duncan Porter	1999	84
14	Lymphadenopathy in a patient with systemic onset juvenile chronic arthritis Annals of the Rheumatic Diseases ·(unknown), Robin Munro, Duncan Porter, R D Sturrock	1998	14
15	Absence of gold sodium thiosulfate contact hypersensitivity in rheumatoid arthritis Contact Dermatitis ·Colin Fleming, Duncan Porter, Rona M. MacKie	1998	4
16	Myocrisin-mediated oxidative stress Clinica Chimica Acta ·J. Reglinski, Duncan E. Paterson, Boyuan Cheng, Mohamed Bendahan, Rhoda Wilson, Duncan Porter, R D Sturrock, W. Ewen Smith	1997	8
17	Effect of social deprivation on disease severity and outcome in patients with rheumatoid arthritis Annals of the Rheumatic Diseases ·Anne McEntegart, Elaine Morrison, H A Capell, Choon Lian Ng, Duncan Porter, Rajan Madhok, 严济良	1997	67
18	THE ‘NATURAL’ HISTORY OF ACTIVE RHEUMATOID ARTHRITIS OVER 3–6 MONTHS—AN ANALYSIS OF PATIENTS ENROLLED INTO TRIALS OF POTENTIAL DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS, AND TREATED WITH PLACEBO Lara D. Veeken ·Duncan Porter, H A Capell	1993	10
19	Medical management of rheumatoid arthritis. BMJ ·Duncan Porter, R D Sturrock	1993	8
20	PNEUMOCYSTIS CARINII INFECTION COMPLICATING CYTOTOXIC THERAPY IN TWO PATIENTS WITH LYMPHOPENIA, BUT A NORMAL TOTAL WHITE CELL COUNT Lara D. Veeken ·Duncan Porter, Aniel K. Diala, Rajan Madhok, H A Capell, R D Sturrock	1992	17

About Duncan Porter

Duncan Porter is a scholar working on Rheumatology, Hematology, Genetics, Hepatology and Pharmacology, having authored 65 papers that have together received 2.7k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (48 papers), Systemic Lupus Erythematosus Research (23 papers), Autoimmune and Inflammatory Disorders Research (17 papers), Chronic Lymphocytic Leukemia Research (8 papers), Lymphoma Diagnosis and Treatment (6 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers), Spondyloarthritis Studies and Treatments (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). The work is most often cited by research in Rheumatology (2.2k citations), Hematology (918 citations), Genetics (429 citations), Immunology (497 citations) and Pathology and Forensic Medicine (341 citations). Duncan Porter has collaborated with scholars based in United Kingdom, Canada and United States. Frequent co-authors include A. Stirling, W. Kincaid, Alex D. McMahon, R. Vallance, Hilary A. Capell, Peter Lock, Iain B. McInnes, H A Capell, Robin Munro and James Dale. Their work appears in journals such as Annals of the Rheumatic Diseases, RMD Open, Lara D. Veeken, Arthritis Care & Research and Scandinavian Journal of Rheumatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact